Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
   CNBC Daily Open: October’s gravity bringing stocks down
   
  
  
  October 04, 2024
  From CNBC.com News
 
   Friday's big stock stories: What’s likely to move the market in the next trading session
   
  
  October 03, 2024
  From CNBC.com News
 
   Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
   
  
  October 01, 2024
  From CNBC.com News
 
   East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
   
  
  October 01, 2024
  From CNBC.com News
 
   Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
   
  
  September 25, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Wednesday
   
  
  September 25, 2024
  From CNBC.com News
 
   Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
   
  
  September 24, 2024
  From CNBC.com News
 From CNBC.com News
 
   Tuesday's big stock stories: What's likely to move the market in the next trading session
   
  
  September 23, 2024
  From CNBC.com News
 
   Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
   
  
  
  September 22, 2024
  From Benzinga
 
   FTC sues drug middlemen for allegedly inflating insulin prices
   
  
  September 20, 2024
  From CNBC.com News
 
   Novartis not joining the 'frenzy' of weight loss drugs, CEO says
   
  
  September 18, 2024
  From CNBC.com News
 From CNBC.com News
 
   How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
   
  
  September 16, 2024
  From CNBC.com News
 
   CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
   
  September 12, 2024
  Tickers 
   JOBS
  
  
  From CNBC.com News
 
   Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
   
  
  September 12, 2024
  From CNBC.com News
 
   Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
   
  
  September 10, 2024
  From CNBC.com News
 
   Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
   
  
  September 05, 2024
  From CNBC.com News
 
   5 things to know before the stock market opens Tuesday
   
  
  September 03, 2024
  From CNBC.com News
 
   Weight loss drugs cut Covid-19 deaths, study finds
   
  
  September 02, 2024
  From CNBC.com News
 
   Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
   
  
  August 27, 2024
  From CNBC.com News
 
   Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
   
  
  August 21, 2024
  From CNBC.com News
 
   Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
   
  
  August 20, 2024
  From CNBC.com News
 From CNBC.com News
 
   Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
   
  
  August 15, 2024
  From CNBC.com News
 
   Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
   
  
  August 14, 2024
  From CNBC.com News
 
   Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
   
  
  August 13, 2024
  From CNBC.com News
 From CNBC.com News
 From CNBC.com News
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
